The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NASCOBAL 500 MCG NASAL SPRAYS. The contract has a potential value of $2,541.46 and a performance period through March 6, 2024. Amerisourcebergen Drug Corp, as a prime contractor, is responsible for delivering these pharmaceutical products to support military treatment programs and facilities. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of medications and healthcare materials to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Generated 6/4/24, 9:56 AM